Skip to main content

The PrecISE Clinical Trial for Severe Asthma

PrecISE (Precision Interventions for Severe Asthma) is a three-year clinical trial that aims to identify more effective treatments for severe asthma, which affects nearly 10% of people living with asthma worldwide. The study will use an adaptive designed clinical trial that will support a personalized medicine approach to identifying therapies which are tailored to an individual’s disease and treatment history. PrecISE is sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

asthma-research.jpgYour participation matters. Help us uncover new insights into asthma and improve patient care.

For more information about PrecISE, call us at (619) 431-0995 or email us at